A new study reveals the involvement of interleukin-33, an important alarm signal, when immune cells get exposed to Sars-CoV-2 for a second time. Early in the coronavirus pandemic, a team of ...

The study points to the involvement of Interleukin 33, an important danger signal, when immune cells encounter Sars-CoV-2 for a second time. We started the study at a very early stage of the ...

In a recent study published in Nature Communications, researchers investigated the effects of statins via inhibition of interleukin 33 (IL-33). This epithelial-derived alarmin cytokine promotes ...

Investigators at Massachusetts General Hospital (MGH) who previously demonstrated high expression levels of an immune molecule called interleukin-33 (IL-33) during cancer-promoting inflammation have ...

Itepekimab is a new monoclonal antibody against the upstream alarmin interleukin-33. The efficacy and safety of itepekimab as monotherapy, as well as in combination with dupilumab, in patients ...

For patients with moderate to severe asthma, blockade with itepekimab, a new human IgG4P monoclonal antibody against the upstream alarmin interleukin-33, led to a reduction in events that indicate ...

Regeneron (NASDAQ:REGN) shares fell ~18% to reach a new 52-week low as a Phase 3 trial failure for its antibody therapy itepekimab, developed with Sanofi (SNY) for a lung disorder known as chronic ...

The study points to the involvement of Interleukin 33, an important danger signal, when immune cells encounter Sars-CoV-2 for a second time. “We started the study at a very early stage of the pandemic ...

Investigators at Massachusetts General Hospital (MGH) who previously demonstrated high expression levels of an immune molecule called interleukin-33 (IL-33) during cancer-promoting inflammation have ...

The study points to the involvement of Interleukin 33, an important danger signal, when immune cells encounter Sars-CoV-2 for a second time. "We started the study at a very early stage of the ...